Editor Profile

Hensin Tsao, MD, PhD


About the NEJM Journal Watch Dermatology Board

Hensin Tsao, MD, PhD, is Professor of Dermatology at Harvard Medical School. Dr. Tsao is a physician-scientist with special interest in cancer genetics and the clinical management of cutaneous melanoma. He attends at the Massachusetts General Hospital Melanoma Center, where he directs the Melanoma Genetics Program and the Melanoma and Pigmented Lesion Center, and dedicates much of his time to educating medical students, dermatology residents, and fellows. Dr. Tsao lectures internationally about melanoma and genetics and has published widely in basic and clinical dermatology research. He has been writing about basic science studies for NEJM Journal Watch Dermatology since 2001, and has served as Editor-in-Chief since 2010.


Consultant / Advisory board

Genentech; Quest Diagnostics; WorldCare Clinical

Grant / Research support

NIH; Department of Defense; American Skin Association

Editorial boards

British Journal of Dermatology; Journal of the American Academy of Dermatology; Journal of Investigative Dermatology

Leadership positions in professional societies

American Academy of Dermatology (Chair, Skin Cancer and Melanoma Committee); American Board of Dermatology (Director)

Summaries by Hensin Tsao

  • April 10, 2014

    Nivolumab and Melanoma

    1. Hensin Tsao, MD, PhD

    This follow-up study confirms survival benefit and demonstrates long-term safety and response duration.

  • April 4, 2014

    UV Inflammation and Melanoma

    1. Hensin Tsao, MD, PhD

    Ultraviolet exposure correlated with neutrophilic inflammation, perivascular invasion, and spontaneous lung metastases in a mouse model of melanoma.

  • March 24, 2014

    Unraveling Spitz Tumors

    1. Hensin Tsao, MD, PhD

    Every mole starts out with the ambition to become a melanoma, including spitzoid neoplasms.

  • March 21, 2014

    Ulceration and Melanoma

    1. Hensin Tsao, MD, PhD

    Higher incidence of ulcerated melanoma in older men may explain their higher associated mortality.

  • February 12, 2014

    Sentinel Lymph Node Biopsy versus Nodal Observation in Melanoma

    1. Hensin Tsao, MD, PhD

    Despite a lack of treatment-related survival benefit, SLNB protected against microscopic nodal recurrence, and survival among patients with such disease was significantly better.

  • January 10, 2014

    Men, Melanoma, and Mortality

    1. Hensin Tsao, MD, PhD

    Since 1950, melanoma incidence has increased more than 20-fold in older men, and the rate of associated mortality in men has tripled.